12:00 AM
 | 
May 27, 2013
 |  BC Week In Review  |  Company News  |  Other News

Vivus endocrine/metabolic news

Vivus investor First Manhattan Co. added three additional nominees, including Alex Denner, to its slate of proposed directors for the biotech's board. Denner had been a managing director of entities associated with Carl Icahn since 2006,...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >